Original article
Deep Vein Thrombosis of the Upper Extremity
Dtsch Arztebl Int 2017; 114: 244-9. DOI: 10.3238/arztebl.2017.0244
; ; ; ;
| 1. | Bleker SM, van Es N, Kleinjan A, et al.: Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis. JTH 2016; 14: 973–81 CrossRef |
| 2. | Grant JD, Stevens SM, Woller SC, et al.: Diagnosis and management of upper extremity deep-vein thrombosis in adults. JTH 2012; 108: 1097–108 CrossRef |
| 3. | Moher D, Liberati A, Tetzlaff J, Altman DG, Group P: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med 2009; 3: 123–30 CrossRef CrossRef CrossRef CrossRef CrossRef |
| 4. | Cote LP, Greenberg S, Caprini JA, et al.: Comparisons between upper and lower extremity deep vein thrombosis: a review of the RIETE registry. Clin Appl Thromb Hemost 2016; pii: 1076029616663847 (epub ahead of print) CrossRef MEDLINE |
| 5. | Encke A, Haas S, Kopp I: The prophylaxis of venous thromboembolism. Dtsch Arztebl Int 2016; 113: 532–8 VOLLTEXT |
| 6. | Sajid MS, Ahmed N, Desai M, Baker D, Hamilton G: Upper limb deep vein thrombosis: a literature review to streamline the protocol for management. Acta Haematol 2007; 118: 10–8 CrossRef MEDLINE |
| 7. | Margey R, Schainfeld RM: Upper extremity deep vein thrombosis: the oft-forgotten cousin of venous thromboembolic disease. Curr Treat Options Cardiovasc Med 2011; 13: 146–58 CrossRef MEDLINE |
| 8. | Lee JA, Zierler BK, Zierler RE: The risk factors and clinical outcomes of upper extremity deep vein thrombosis. Vasc Endovascular Surg 2012; 46: 139–44 CrossRef MEDLINE |
| 9. | Stone RH, Bress AP, Nutescu EA, Shapiro NL: Upper-extremity deep-vein thrombosis: a retrospective cohort evaluation of thrombotic risk factors at a university teaching hospital antithrombosis clinic. Ann Pharmacother 2016; 50: 637–44 CrossRef MEDLINE |
| 10. | Joffe HV, Goldhaber SZ: Upper-extremity deep vein thrombosis. Circulation 2002; 106: 1874–80 CrossRef |
| 11. | Spencer FA, Emery C, Lessard D, Goldberg RJ, Worcester Venous Thromboembolism Study: Upper extremity deep vein thrombosis: a community-based perspective. Am J Med 2007; 120: 678–84 CrossRef MEDLINE PubMed Central |
| 12. | Joffe HV, Kucher N, Tapson VF, Goldhaber SZ; Deep Vein Thrombosis (DVT) FREE Steering Committee: Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation 2004; 110: 1605–11 CrossRef MEDLINE |
| 13. | Baskin JL, Pui CH, Reiss U, et al.: Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet 2009; 374: 159–69 CrossRef |
| 14. | Grove JR, Pevec WC: Venous thrombosis related to peripherally inserted central catheters. JVIR 2000; 11: 837–40 CrossRef |
| 15. | Evans RS, Sharp JH, Linford LH, et al.: Risk of symptomatic DVT associated with peripherally inserted central catheters. Chest 2010; 138: 803–10 CrossRef MEDLINE |
| 16. | Da Costa SS, Scalabrini Neto A, Costa R, Caldas JG, Martinelli Filho M: Incidence and risk factors of upper extremity deep vein lesions after permanent transvenous pacemaker implant: a 6-month follow-up prospective study. Pacing Clin Electrophysio 2002; 25: 1301–6 CrossRef |
| 17. | Blom JW, Doggen CJ, Osanto S, Rosendaal FR: Old and new risk factors for upper extremity deep venous thrombosis. JTH 2005; 3: 2471–8 CrossRef |
| 18. | Mino JS, Gutnick JR, Monteiro R, Anzlovar N, Siperstein AE: Line-associated thrombosis as the major cause of hospital-acquired deep vein thromboses: an analysis from National Surgical Quality Improvement Program data and a call to reassess prophylaxis strategies. Am J Surg 2014; 208: 45–9 CrossRef MEDLINE |
| 19. | Kucher N: Clinical practice. Deep-vein thrombosis of the upper extremities. N Engl J Med 2011; 364: 861–9 CrossRef MEDLINE |
| 20. | Engelberger RP, Kucher N: Management of deep vein thrombosis of the upper extremity. Circulation 2012; 126: 768–73 CrossRef MEDLINE |
| 21. | van Es N, Bleker SM, di Nisio M, et al.: A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients. Thromb Res 2016; 148: 59–62 CrossRef MEDLINE |
| 22. | Constans J, Salmi LR, Sevestre-Pietri MA, et al.: A clinical prediction score for upper extremity deep venous thrombosis. Thromb Haemost 2008; 99: 202–7 MEDLINE |
| 23. | van Es N, van der Hulle T, Buller HR, et al.: Is stand-alone D-dimer testing safe to rule out acute pulmonary embolism? JTH 2017 (Epub ahead of print). |
| 24. | El Tabei L, Holtz G, Schurer-Maly C, Abholz HH: Accuracy in diagnosing deep and pelvic vein thrombosis in primary care: an analysis of 395 cases seen by 58 primary care physicians. Dtsch Arztebl Int 2012; 109: 761–6 VOLLTEXT |
| 25. | Di Nisio M, van Sluis GL, Bossuyt PM, Buller HR, Porreca E, Rutjes AW: Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review. JTH 2010; 8: 684–92 CrossRef |
| 26. | AWMF: S2k-Diagnostik und Therapie der Venenthrombose und der Lungenembolie. www.awmf.org/leitlinien/detail/ll/003–001.html (last accessed on 25 December 2016). |
| 27. | van den Houten MM, van Grinsven R, Pouwels S, Yo LS, van Sambeek MR, Teijink JA: Treatment of upper-extremity outflow thrombosis. Phlebology 2016; 31: 28–33 CrossRef MEDLINE |
| 28. | Schlitt A, Jambor C, Spannagl M, Gogarten W, Schilling T, Zwissler B: The perioperative management of treatment with anticoagulants and platelet aggregation inhibitors. Dtsch Arztebl Int 2013; 110: 525–32 VOLLTEXT |
| 29. | Kearon C, Akl EA, Comerota AJ, et al.: Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141: e419S–94S. |
| 30. | Lin PH, Zhou W, Dardik A, et al.: Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis. Am J Surg 2006; 192: 782–8 CrossRef MEDLINE |
| 31. | Cynamon J, Stein EG, Dym RJ, Jagust MB, Binkert CA, Baum RA: A new method for aggressive management of deep vein thrombosis: retrospective study of the power pulse technique. JVIR 2006; 17: 1043–9 CrossRef MEDLINE |
| 32. | Munoz FJ, Mismetti P, Poggio R, et al.: Clinical outcome of patients with upper-extremity deep vein thrombosis: results from the RIETE Registry. Chest 2008; 133: 143–8 CrossRef MEDLINE |
| 33. | Lee AY, Levine MN, Baker RI, et al.: Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003; 349: 146–53 CrossRef MEDLINE |
| 34. | Lee AY, Bauersachs R, Janas MS, et al.: CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients. BMC Cancer 2013; 13: 284 CrossRef MEDLINE PubMed Central |
| 35. | Lee AY, Kamphuisen PW, Meyer G, et al.: Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: a randomized clinical trial. JAMA 2015; 314: 677–86 CrossRef MEDLINE |
| 36. | Enden T, Haig Y, Klow NE, et al.: Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet 2012; 379: 31–8 CrossRef |
| 37. | Vedantham S: Interventions for deep vein thrombosis: reemergence of a promising therapy. Am J Med 2008; 121: 28–39 CrossRef |
| 38. | O‘Sullivan GJ, Lohan DG, Gough N, Cronin CG, Kee ST: Pharmacomechanical thrombectomy of acute deep vein thrombosis with the Trellis-8 isolated thrombolysis catheter. JVIR 2007; 18: 715–24 CrossRef MEDLINE |
| 39. | Verso M, Agnelli G, Bertoglio S, et al.: Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. J Clin Oncol 2005; 23: 4057–62 CrossRef MEDLINE |
| 40. | Monreal M, Alastrue A, Rull M, et al.: Upper extremity deep venous thrombosis in cancer patients with venous access devices—prophylaxis with a low molecular weight heparin (Fragmin). JTH 1996; 75: 251–3. |
| e1. | Schulman S, Kearon C, Kakkar AK, et al.: Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med 2009; 361: 2342–52 CrossRef MEDLINE |
| e2. | Schulman S, Kakkar AK, Goldhaber SZ, et al.: Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis. Circulation 2014; 129: 764–72 CrossRef MEDLINE |
| e3. | Bauersachs R, Berkowitz SD, Brenner B, et al.: Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010; 363: 2499–510 CrossRef MEDLINE |
| e4. | Buller HR, Prins MH, Lensin AW, et al.: Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 2012; 366: 1287–97 CrossRef MEDLINE |
| e5. | Agnelli G, Buller HR, Cohen A, et al.: Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 2013; 369: 799–808 CrossRef MEDLINE |
| e6. | Hokusai VTEI, Buller HR, Decousus H, et al.: Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med 2013; 369: 1406–15 CrossRef MEDLINE |
| e7. | Lyman GH, Khorana AA, Falanga A, et al.: American Society of clinical oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol Oncology 2007; 25: 5490–505 CrossRef MEDLINE |
| e8. | Mandala M, Falanga A, Roila F, Group EGW: Management of venous thromboembolism (VTE) in cancer patients: ESMO clinical practice guidelines. Ann Oncol 2011; 22 (Suppl 6): vi85–92 MEDLINE |
| e9. | Khorana AA: The NCCN clinical practice guidelines on venous thromboembolic disease: strategies for improving VTE prophylaxis in hospitalized cancer patients. Oncologist 2007; 12: 1361–70 CrossRef MEDLINE |
| e10. | AWMF: S3-Leitlinie Prophylaxe der venösen Thromboembolie (VTE). www.awmf.org/leitlinien/detail/ll/003–001.html (last accessed on 25 December 2016). |
| e11. | Flinterman LE, van der Meer FJ, Rosendaal FR, Doggen CJ: Current perspective of venous thrombosis in the upper extremity. J Thromb Haemost 2008; 6: 1262–6 CrossRef MEDLINE |
| e12. | Urschel HC, Jr., Patel AN: Paget-Schroetter syndrome therapy: failure of intravenous stents. Ann Thorac Surg 2003; 75: 1693–6 CrossRef |
| e13. | Urschel HC, Jr., Razzuk MA: Paget-Schroetter syndrome: what is the best management? Ann Thorax Surg 2000; 69: 1663–8 CrossRef |
| e14. | Schleyer AM, Jarman KM, Calver P, Cuschieri J, Robinson E, Goss JR: Upper extremity deep vein thrombosis in hospitalized patients: a descriptive study. J Hosp Med 2014; 9: 48–53 CrossRef MEDLINE |
| e15. | Kovacs MJ, Kahn SR, Rodger M, et al.: A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (the catheter study). J Thromb Haemost 2007; 5: 1650–3 CrossRef MEDLINE |
